NCT04298606: A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Sponsor: Roswell Park Cancer Institute. Phase: EARLY_PHASE1. Conditions: Chronic Obstructive Pulmonary Disease, Lung Non-Small Cell Carcinoma, Pneumonia, Stage IB Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8